Most gene therapy protocols rely on recombinant viral vectors for transfection, but that has not been without problems.  However, a new process of nanochannel electroporation, developed at Ohio State University, holds the possibility of transforming stem cells, one at a time with a precise amount of DNA or protein, for a safer therapeutic approach.  MORE